Imojev in Australia
January 8, 2013
IMOJEV, the first vaccine to offer
single dose primary immunisation
against Japanese encephalitis, is
now available to Australian
healthcare professionals for
immediate use.
The vaccine, manufactured by
Sanofi Pasteur, is recommended for
patients traveling to India, and
South East Asia including China,
particularly for those visiting friends
or relatives in rural areas.
Japanese encephalitis is
transmitted by mosquitos, which
acquire the virus mostly from pigs
or water birds, and impacts an
estimated 50,000 people across the
globe a year with 10,000 deaths.
The primary course of vaccination
for both adults and children is a
single dose, two weeks prior to
travel, with the dose predicted to
last for four years in over 91% of adults.
The above article was sent to subscribers in Pharmacy Daily's issue from 08 Jan 13To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 08 Jan 13